Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$305,200,840
+$58,970,136 QoQ
Shares Held
331,823
+44.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WORLDQUANT MILLENNIUM ADVISORS LLC holds $740,904,213 across 7 Drug Manufacturers - General names. LLY ranks #1 (41.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
331,823 | $305,200,840 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,392,094 | $205,730,501 | |
| 3 | ABBV |
AbbVie Inc.
|
536,277 | $116,634,884 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
429,035 | $59,794,607 | |
| 5 | AMGN |
Amgen Inc
|
95,027 | $33,435,249 | |
| 6 | AZN |
Astrazeneca PLC
|
100,830 | $19,885,692 | |
| 7 | JNJ |
Johnson & Johnson
|
910 | $222,440 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $305,200,840 | 331,823 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $246,230,704 | 229,120 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $122,718,631 | 160,837 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $72,340,384 | 92,800 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $97,676,246 | 118,265 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $101,062,520 | 130,910 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $168,771,570 | 190,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,996,253 | 17,668 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $46,310,402 | 59,528 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $26,551,423 | 45,549 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $52,626,386 | 97,977 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,944,456 | 10,543 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $33,735,863 | 98,235 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $26,397,916 | 72,157 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,667,316 | 32,990 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,876,747 | 95,231 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $18,573,958 | 64,860 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,607,240 | 9,439 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,262,423 | 79,041 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $17,786,112 | 105,343 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,592,870 | 105,343 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $17,162,720 | 104,536 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,117,274 | 44,098 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||